Invited Talks
2022
Transparency v. Accessibility in Decision-Analytic Models, ISPOR Open Source Modeling Interest Group, 2022-05-16 (virtual)
The role of economic evaluation in healthcare and research: a primer, ImmunoT Immunotherapeutics Research Symposium, 2022-09-16 (virtual)
Predicting Exacerbations of COPD: Potential for a ‘Precision Surveillance’ approach?, Kaiser Permanente Internal Medicine Rounds, 2022-03-09 (virtual)
Cost Effectiveness of ICS/LABA as Relievers, Nemacolin Asthma Conference, 2022-10-21 (virtual)
Precision Medicine and COPD: Walking the Talk Together, UBC / VGH Respiratory Rounds, 2022-09-15 (virtual)
2021
Peer Models Network: Decision-Analytic Models on the Cloud, R-HTA Seminar, 2021-07-01 (virtual)
Intro to Health Economics and Cost-Effectiveness Analysis, UBC Department of Medicine's Academic Half-day, 2021-05-06 (virtual)
Peer Models Network: Decision-Analytic Models on the Cloud, R-HTA Annual Seminar, 2021-05-06 (virtual)
Can we do a better job in identifying frequent COPD exacerbators? Yes we can, and the impact on clinical practice can be significant, University of Alberta's Respiratory Rounds, 2021-04-21 (virtual)
Creating a reference policy model and making it accessible to the world, Canadian Centre for Health Economics Seminars, 2021-04-16 (virtual)
Model-based ROC (mROC) Curve: A Method for Assessing the Effect of Case-mix and Model Calibration on the ROC Curve, Joint Statistical Meeting, 2021-08-11 (virtual)
2020
What does asthma cost the society?, International COPD and Asthma Conference, 2020-11-17 (virtual)
Can we do a better job in identifying frequent COPD exacerbators?, University of Toronto Respiratory Grand Rounds, 2020-02-14
2019
Asthma Control in Canada, Western Canada Respiratory Scientific Exchange Forum, Calgary, Alberta, Canada, 2019-11-30
Unmet medical needs in inhaler-based therapies in Canada, Teva Canada National Connected Meeting, Montreal, Quebec, Canada, 2019-11-29
The ACute COPD Exacerbation Prediction Tool (ACCEPT), Heart and Lung Institute Rounds, Vancouver, BC, Canada, 2019-09-13
The ‘guideline utopia’ and ‘real world’ of COPD medications, COPD In-focus Program, Toronto, ON, Canada, 2019-04-30
Global measures for capacity of subgroup-defining variables to yield efficient treatment rules, Biostatistics Seminars, McGill University, Montreal, QC, Canada, 2019-01-15
PRISM: Decision-analytic models on the cloud, Society for Medical Decision Making 41st Annual Meeting, Portland, Oregon, USA, 2019-10-22
2018
From ROC to RIC: New metrics for documenting the clinical utility of (bio)markers & risk prediction scores, Centre for Health Evaluation and Outcome Sciences – Work In Progress Seminar Series, Vancouver, BC, Canada, 2018-11-21
Clinical Theme Presentation (with Shawn Aaron and Christopher Carlsten): Creation of a Pan-Canadian Airways Network, Vancouver, BC, Canada, 2018-11-05
Trends in COPD medication use in BC, Ministry of Health/PharmaCare & BC Lung Association Meeting, Vancouver, BC, Canada, 2018-07-27
It is never too early: keeping an eye on clinical utility at early stages of biomarker development, Genomics Forum 2018, Vancouver, BC, Canada, 2018-05-24
Heterogeneity in the Rate and Severity of Exacerbations in Severe Eosinophilic Asthma: Insight from a Pooled Analysis of Two Large Clinical Trials, American Thoracic Society Annual Conference, San Diego, California, USA, 2018-05-23
Conceptualization, development, and validation of a population-based whole-disease microsimulation model of COPD (EPIC), CADTH Annual Conference, Halifax, NS, Canada, 2018-04-17
Asthma outcomes in children: A multi-provincial initiative in Canada, Respiratory Effectiveness Group Annual Summit, Amsterdam, the Netherlands, 2018-03-24
An Introduction to Cost-Effectiveness Analysis (CEA), AAAAI & World Allergy Organization Joint Conference, Orlando, Florida, USA, 2018-03-04
Basics of Health Economics and How to Make Sense of a Cost-effectiveness Analysis, Academic Half-day, UBC Department of Medicine, Vancouver, BC, Canada, 2018-01-28
2017
Developing a Reference Model for Precision Medicine Technologies in COPD: challenges, rewards, and lessons learned, THETA Collaborative, Toronto, ON, Canada, 2017-12-04
The Economic Burden of Asthma and COPD in Canada, Centre de recherche de l'HSCM, Montreal, QC, Canada, 2017-10-23
Inappropriate SABA use in (mild) asthma: extent, trends, predictors, and outcomes, AstraZeneca Canada Advisory Board, Toronto, ON, Canada, 2017-09-29
COPD in BC: Extent and trends of its burden, and medication utilization, Boehringer Ingelheim Advisory Board, Vancouver, BC, Canada, 2017-09-02
The Economic Burden of Asthma (EBA): Concluding Remarks, Heart and Lung Institute, Vancouver, BC, Canada, 2017-06-09
Respiratory Evaluation Sciences Program (RESP): Innovations in analytic approaches to improve efficiency in respiratory care, Canadian Society of Pharmaceutical Sciences (New Investigator Recipient Presentation), Montreal, QC, Canada, 2017-05-12
Economics and the COPD Landscape, Heart and Lung Fest, Vancouver, BC, Canada, 2017-03-16
Burden of COPD in BC: where it stands, where it is heading, and how we can curb the curve (with J. Mark FitzGerald), BC Ministry of Health Research Rounds, Victoria, BC, Canada, 2017-02-28
2016
Evidence-Informed, Value-Driven Asthma Outcomes Program, AllerGen Annual Meeting, Vancouver, BC, Canada, 2016-06-01
Fast and Furious: The Changing Face of the Economic Burden of Asthma, COPD, and Their Overlap, Canadian Respiratory Conference, Halifax, NS, Canada, 2016-04-15
Respiratory Evaluation Sciences Program (RESP): Innovations in analytic approaches to improve efficiency in respiratory care, Research Day, Memorial University, St. John’s, NL, Canada, 2016-03-23
Respiratory Evaluation Sciences Program (RESP): Innovations in analytic approaches to improve efficiency in respiratory care, UBC Faculty of Pharmaceutical Sciences Seminars, Vancouver, BC, Canada, 2016-03-02
Is There Causal Association Between Past and Future Acute Exacerbations of COPD? Evidence from a Population-based Study, American Thoracic Society Annual Conference, Denver, CO, USA, 2016-05-15
2015
Health Economics in Heart and Lung: Making Your Money Work for You (and the Society), Heart and Lung Fest, Vancouver, BC, Canada, 2015-03-25
How to integrate external evidence into within-trial economic evaluations?, CADTH Annual Conference, Ottawa, ON, Canada, 2015-04-13
In Search of Efficiency, Consistency, Fairness, and Impact in HTA: The Case for Clinical Pathway Management and Modelling (with Stirling Bryan and Graham Scotland), CADTH Annual Conference, Ottawa, ON, Canada, 2015-04-13
2014
The journey through academia: advice from new investigators, 9th AllerGen Trainee Symposium, Vancouver, BC, Canada, 2014-05-01
Long-term outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge, Respiratory Effectiveness Group Summit, London, UK, 2014-05-04
The Economic Burden of Asthma in BC, Heart and Lung Fest, Vancouver, BC, Canada, 2014-02-07
2013
Analysis of Asthma and Asthma Care Costs from a Canadian Perspective, 9th World Congress on Health Economics, Sydney, Australia, 2013-07-06
Systems Approach in Chronic Respiratory Disease, IHLH Leader’s Breakfast, Vancouver, BC, Canada, 2013-06-03
The Economic Burden of Asthma, Heart and Lung Fest, Vancouver, BC, Canada, 2013-02-22
Poster Presentation Preparation vs. Manuscript Preparation Workshop, PharGS (UBC Faculty of Pharmaceutical Sciences), Vancouver, BC, Canada, 2013-04-25
2012
Use of complementary and alternative therapies in patients with asthma: preliminary results from a prospective study, World Congress of Asthma, Quebec City, QC, Canada, 2012-08-20
Asthma control in a random sample of Canadian asthma patients, World Congress of Asthma, Quebec City, QC, Canada, 2012-08-19